Lyell Immunopharma, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.84 | $-1.34 |
| FY2022 | $-0.74 | $-1.21 |
| FY2023 | $-18.70 | $-4.82 |
| FY2024 | $-26.23 | $-8.38 |
| FY2025 | $-16.06 | $-9.48 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.84 | $-1.34 |
| FY2022 | $-0.74 | $-1.21 |
| FY2023 | $-18.70 | $-4.82 |
| FY2024 | $-26.23 | $-8.38 |
| FY2025 | $-16.06 | $-9.48 |